| Dr Winston Hong, MD | |
|
2976 Chapel Hill Rd Ste 300b, Douglasville, GA 30135-1734 | |
| (678) 715-3334 | |
| Not Available |
| Full Name | Dr Winston Hong |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 2976 Chapel Hill Rd Ste 300b, Douglasville, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235664442 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 95313 (Georgia) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 95313 (Georgia) | Primary |
| Entity Name | Piedmont Cardiology Of Atlanta, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275729691 PECOS PAC ID: 0345321691 Enrollment ID: O20080114000153 |
News Archive
Deploying a suspension of cells generated from a ReCell® medical device onto a skin donor site can speed up healing by 30.7% and deliver a superior final outcome, according to the results of a randomized controlled trial involving 106 patients who received skin grafts, Avita Medical, said today.
Hugh S. Taylor, M.D., professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale, and colleagues have found that women without mutations of the HOXA13 gene do not need to be subjected to x-rays and other tests for a rare condition called hand-foot genital syndrome. The research is presented at the American Society for Reproductive Medicine (ASRM) scientific meeting in Atlanta, Georgia, October 17-21.
SRI International, an independent nonprofit research and development institute, has received a $3.8M contract from the Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA). SRI will research and develop a device to triage individuals who may have been exposed to ionizing radiation after a radiological or nuclear incident.
China Pediatric Pharmaceuticals, Inc., today announced it has applied for listing approval on the NASDAQ Capital Market ("NASDAQ").
Icon Bioscience, Inc., (IBI), a privately held biopharmaceutical company that specializes in the development and commercialization of novel ophthalmic pharmaceuticals announced today that it has initiated its Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090 in patients undergoing cataract surgery.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Winston Hong, MD 1250 E Marshall St, Box 980509, Richmond, VA 23298-5051 Ph: () - | Dr Winston Hong, MD 2976 Chapel Hill Rd Ste 300b, Douglasville, GA 30135-1734 Ph: (678) 715-3334 |
News Archive
Deploying a suspension of cells generated from a ReCell® medical device onto a skin donor site can speed up healing by 30.7% and deliver a superior final outcome, according to the results of a randomized controlled trial involving 106 patients who received skin grafts, Avita Medical, said today.
Hugh S. Taylor, M.D., professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale, and colleagues have found that women without mutations of the HOXA13 gene do not need to be subjected to x-rays and other tests for a rare condition called hand-foot genital syndrome. The research is presented at the American Society for Reproductive Medicine (ASRM) scientific meeting in Atlanta, Georgia, October 17-21.
SRI International, an independent nonprofit research and development institute, has received a $3.8M contract from the Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA). SRI will research and develop a device to triage individuals who may have been exposed to ionizing radiation after a radiological or nuclear incident.
China Pediatric Pharmaceuticals, Inc., today announced it has applied for listing approval on the NASDAQ Capital Market ("NASDAQ").
Icon Bioscience, Inc., (IBI), a privately held biopharmaceutical company that specializes in the development and commercialization of novel ophthalmic pharmaceuticals announced today that it has initiated its Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090 in patients undergoing cataract surgery.
› Verified 9 days ago
Safal Shetty, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6001 Professional Pkwy Ste 2020, Douglasville, GA 30134 Phone: 770-422-1372 | |
Michael B Piansky, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6043 Prestley Mill Rd Ste B, Douglasville, GA 30134 Phone: 770-941-8100 Fax: 678-945-9331 | |
Navinchandra M Ruparelia, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 4904 Timber Ridge Dr, Suite 202a, Douglasville, GA 30135 Phone: 770-949-6548 Fax: 770-949-9561 | |
Dr. Gray Akoegbe, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6001 Professional Pkwy Ste 2080, Douglasville, GA 30134 Phone: 678-715-5080 | |
Neal K Osborn, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8855 Hospital Dr, Suite 101, Douglasville, GA 30134 Phone: 678-784-5020 Fax: 678-784-5024 | |
Dr. Kathryn Amanda Mcfarland, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8687 Hospital Dr Ste 102, Douglasville, GA 30134 Phone: 678-785-5001 Fax: 888-464-0963 | |
Dr. Nana Abena Arthur, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8954 Hosptial Drive, Wellstar Health System Douglas Hospital, Douglasville, GA 30134 Phone: 678-838-2585 |